Related Experiment Video
Updated: May 18, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Can mycoplasma contribute to formation of prostate cancer?
Sakip M Erturhan1, Omer Bayrak, Sacide Pehlivan
1Department of Urology, School of Medicine, University of Gaziantep, 27310 Gaziantep, Turkey.
Purpose:
To reveal the possible role of mycoplasmas in the etiopathogenesis of prostate cancer.
Methods:
In the study, prostate biopsy was performed on 62 patients with an abnormal digital rectal examination and/or elevated PSA. The patients' age was between 62 and 77 (mean 65.4 years) years. Thirty-one patients had adenocarcinoma of the prostate histopathologically (group 1). From these patients, the specimens were divided into two subgroups as specimens with malignant findings (group 1A) and specimens with benign findings (group 1B). The control group consisted of 31 patients with benign prostatic hyperplasia (group 2). In the specimens, the presence of mycoplasma DNA was investigated by the polymerase chain reaction method.
Results:
The mycoplasma DNA was found to be positive in 11 (35.4 %) patients in group 1A and in 4 (12.9 %) patients in group 1B. There was no mycoplasma DNA in the patients in group 2. The differences between group 1A and group 1B, and between group 1A and group 2 were statistically significant (p values, respectively, 0.006 and 0.0001).
Conclusions:
Our data supported the thesis that mycoplasma infections play a role in the etiopathogenesis of the prostate cancer.
Insights
Mycoplasma DNA was detected in prostate cancer patients, suggesting a role for these infections in the development of prostate cancer. Further research is needed to confirm these findings.
Area of Science:
- Urology
- Oncology
- Microbiology
Background:
- Prostate cancer is a significant health concern globally.
- The etiopathogenesis of prostate cancer is multifactorial, with infectious agents being investigated.
- Mycoplasmas are bacteria that lack a cell wall and are known to cause various infections.
Purpose of the Study:
- To investigate the potential association between Mycoplasma infection and prostate cancer.
- To determine if Mycoplasma DNA is present in prostate biopsy samples from patients with prostate cancer.
Main Methods:
- A case-control study was conducted involving 62 patients undergoing prostate biopsy.
- Patients were categorized into three groups: adenocarcinoma of the prostate (malignant and benign findings) and benign prostatic hyperplasia (control).
- Polymerase chain reaction (PCR) was used to detect Mycoplasma DNA in biopsy specimens.
Main Results:
- Mycoplasma DNA was detected in 35.4% of patients with malignant prostate findings (group 1A) and 12.9% of patients with benign findings (group 1B).
- No Mycoplasma DNA was found in the control group (group 2).
- The differences in Mycoplasma DNA detection between group 1A and groups 1B and 2 were statistically significant (p < 0.001).
Conclusions:
- The findings suggest a potential role of Mycoplasma infection in the etiopathogenesis of prostate cancer.
- Mycoplasma infection may be a contributing factor in the development or progression of prostate cancer.
- Further studies are warranted to elucidate the precise mechanisms involved.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Atypical Pneumonia
Microbiota of the Urogenital Tract
Cancer Prevention
Some...
Bacterial Phylum Tenericutes
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
